Cancer Research UK Chooses Medidata Clinical Cloud
Cancer Research UK, a UK-based charitable funder of cancer research, has selected Medidata’s Clinical Cloud® cloud-based technology for EDC and management (Medidata Rave®) for Cancer Research UK’s Center for Drug Development (CDD)-based clinical trials at institutes, universities and hospitals across the UK.
Cancer Research UK, a UK-based charitable funder of cancer research, has selected Medidata’s Clinical Cloud® cloud-based technology for EDC and management (Medidata Rave®) for Cancer Research UK’s Center for Drug Development (CDD)-based clinical trials at institutes, universities and hospitals across the UK. By providing a standardized, central system for data entry, the Medidata platform is intended to improve data quality, allow clinicians to easily monitor patients’ safety and enable more insightful decision making across all CDD trials.
Read the full release here.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
